Environmental Disease | Volume 4 | Issue 1 | January-March 2019 a sweet smell derived from benzene compound. Use of this chemical is quite extensive in paint industry, rubber, cosmetics, adhesive, and printing ink. [1] Major sources of toluene in indoor environment are paint, thinner, together with tobacco smoke.
[2] There are three main routes of toluene exposure, namely inhalation, ingestion, and dermal contact. It is a highly volatile compound; therefore, inhalation is the most important exposure pathway to be considered. Moreover, once it enters into the human body, it gets deposited and accumulated very easily in the vital organs such as the brain, liver, kidneys, and other organs. [3] Chronic exposure can cause health issues such as eye/skin irritation, dizziness, respiratory problems, impaired function of liver, kidney, and central nervous system (CNS). [3, 4] Once toluene is absorbed in the body via respiratory tract, then it is oxidized in liver microsomes mainly (68%) to hippuric acid (HA). [5] HA is normally a main component of nonprotein nitrogen in urine. It is an important metabolic end product for protein or nucleic acid. It is also an established urinary biomarker in biological monitoring of people exposed to toluene. [6, 7] HA is excreted in urine with a half-life of 2-3 h. [8] Metabolic process of toluene is given in Figure 1 . [6] Urinary HA has been extensively studied as an occupational biomarker for toluene exposure. This compound presents a good correlation with the degree of exposure and is one of the recommended biomarkers to assess exposure to toluene. [9] [10] [11] Estimation of this biomarker in urine is one of the most useful ways for biomonitoring of occupational exposure to toluene. [12] Studies reported that the lowest concentration of toluene in breathing environment is 30 ppm at which urinary HA increased to a measurable level. [13, 14] Various methods have been developed for the estimation of HA in urine such as colorimetric, [15] spectrophotometric, and [16] by high-performance liquid chromatography (HPLC). [17] [18] [19] [20] However, all these methods are expensive and require a long sample preparation process. The objective of this work was to develop a simple and cost-effective technique for the measurement of HA in urine, using liquid-liquid extraction (LLE) and HPLC with ODS-2 Hypersil column and photodiode array detector.
MATERIALS AND METHODS

Reagents
HA (98%) as standard was procured from Merck, Germany. All the chemicals and solvents such as hydrochloric acid, sodium chloride, ethyl acetate, acetonitrile, trifluoroacetic acid, and water were of HPLC grade.
Instrument
HPLC (Shimadzu, Japan) consisted of a system controller (Model: SLC-10 A, VP-Series), connected with an automated liquid sampler (Model: LC-10AT, VP series), spectrophotometer (Model: SPD-M 10A, Diode Array Detector), column oven, and a monitor. The column used was ODS-2 Hypersil, 250 mm, 4.6 mm, particle size 5 µm (Thermo).
Chromatographic conditions
The pump was operated at a flow rate of 1 ml/min; UV detection wavelength was set at 205 nm. The mobile phase used was 0.1% trifluoro acetic acid (TFA) in acetonitrile and 0.1% TFA in HPLC grade water with flow of 1 ml/min, sample injection volume was 20 µl, reverse phase analytical column ODS-2 Hypersil (250 mm, 4.6 mm, and 5 µm), and oven temperature 25°C was used for chromatographic system. Under these conditions, HA was eluted and detected in around 18.90 min.
Sample preparation procedure
Well-mixed urine sample (1 ml) was taken in centrifuge tube, added 80 µl of 6N HCL, 0.3 g sodium chloride, and 4 ml ethyl acetate. Then, all the contents of the centrifuge tube were mixed for 2 min by rotation and followed by centrifugation at 1100 rpm for 5 min. Then, 200 µl of the upper (organic) layer was transferred to HPLC vial and evaporated to dryness using a heated (30ºC) water bath and a gentle stream of nitrogen. The dried residue was re-dissolved in 200 µl of distilled water. For analysis, 20 µl of it was injected into the HPLC.
Method validation
Selectivity
Selectivity of the method was evaluated by comparing the analyte retention time (RT) and peak purity obtained for the standard solution and samples.
Linearity
To obtain linearity, working standards containing HA in concentration range 0.5-10 µg/ml were prepared in aqueous solution and analyzed at optimized chromatographic conditions to obtain determination coefficient (R 2 ) from calibration curve of analyte. 
Limit of detection and quantification
Limit of detection (LOD) and limit of quantification (LOQ) for HA were determined based on standard deviation (σ) and slope (S) of calibration curve as per the guidelines of International Conference on Harmonization 2005 (LOD = 3 × σ/S; LOQ = 10 × σ/S).
[21]
Precision
Intraday and interday precision was measured using the coefficient of variation (CV) obtained for repetition of sample preparation to injection onto the chromatographic column. For intraday precision, samples were analyzed for three times within the same day, whereas for interday, test samples were analyzed for 3 consecutive days. Values of up to 20% were normally considered acceptable for analytical methods applied to environmental samples with complex matrices. [22, 23] 
Accuracy
Accuracy was determined using the percentage recovery of HA added to urine at concentrations 2, 3, and 5 µg/ml, with three replicates. [22] Accuracy (%) =100 × (C spiked × C sample )/C std where C spiked denotes concentration of HA added to urine sample, C sample denotes concentration of HA in urine sample determined from calibration curve, and C std denotes concentration of HA standard.
Matrix effects
Interference caused by the presence of the biological matrix was assessed by comparing the coefficient of determination obtained for analytical curve of HA prepared using aqueous solution and urine sample. The LLE was performed under the optimized conditions.
Method validity
In order to validate the present method, biological monitoring was done in urine (five samples of each exposed and unexposed samples used for this work). Urine samples used for this method validation were collected under institutional intramural project, and the project was approved by the Institutional Ethics Committee. Postshift urine samples were collected from toluene-exposed workers and also collected from unexposed individuals used as control. The values of unexposed and exposed individuals were compared by Student's t-test, and P value was determined.
RESULTS
Urinary HA is extensively used as an exposure biomarker of toluene as suggested by statutory bodies. [9, 11] In individuals exposed to toluene vapors such as workers of industries such as shoe making, painters, printing press, and cosmetics, HA in urine of exposed individuals can be found in higher concentrations than unexposed individuals. However, the expected amount of HA in exposed individuals may be 1.5 g/g creatinine as recommended by the American Conference on Hygiene of Governmental Industrial Hygienists. [11] For this reason, it is advantageous to have a simple and easy method that allows the evaluation of this compound in the urine samples. Human urine is a complex matrix that contains proteins, hormones, salts, drugs, and a variety of other compounds. Therefore, to obtain maximum elution of HA from urine, the samples were extracted by LLE method and analyzed at optimized analytical conditions. Under these optimized chromatographic conditions, HA peak for standard solution and urine sample was detected in around 18.90 min at wavelength 205 nm as shown in Figure 2 . Method selectivity was confirmed by comparing the RT of HA peak in the standard and sample chromatogram (A and B), under the same chromatographic conditions, and degree of purity of the eluted peak was determined using the LC solutions software, version 1.25 (Shimadzu, Japan). For peak purity, the evaluation was made from the absorption spectra at the RTs corresponding to the up slope, top, and down slope regions of the chromatographic peak, comparing them in order to identify any possibility of co-elution of other substance. Figure 3 presents the calibration curve with coefficient of determination (R 2 ) value exceeding 0.9986 prepared using aqueous HA standards in the concentration range of 0.5-10 µg/ml. LOD and LOQ of the method were calculated using standard deviation (σ) and slope (S) of calibration curve, as described previously. The values obtained were 0.46 µg/ml (LOD) and 1.53 µg/ml (LOQ). In Table 1 , CV was calculated in order to determine the precision of the method. For intraday study, HA standards and urine sample were analyzed in three replicates, and inter-day study was performed in the same way for 3 consecutive days. The highest values of CV obtained were 1.4% and 8.1% for intra-and inter-day experiments, respectively, demonstrating that the method provided good precision. The results also showed that the precision was independent of the concentration of HA in sample. The accuracy of the method was determined using the recovery of HA standards 2, 3, and 5 µg/ml added to the urine. The concentration of HA in unfortified urine was HA: Hippuric acid, CV: Coefficient of variation 16 µg/ml, calculated from analytical curve prepared using aqueous standards. Accuracy obtained was 96%-120% as shown in Table 2 .
As the method is developed for biological fluids like urine, it is important to evaluate the matrix effect. In our results, the presence of matrix effect was found as shown in Figure 4 . Slope of analytical curve prepared in urine was slightly higher than the analytical curve prepared in aqueous solution. Quantification of results was done with analytical curve prepared in urine to nullify the matrix effect. Displacement of analytical curve for urine and of aqueous solution was due to the presence of HA in urine, which has also been observed in other studies. [5, 24, 25] The present method is validated by evaluating urinary HA concentration, in urine of exposed (shoe workers) and controls. When analytical results of exposed (n = 5) and unexposed (n = 5) groups were compared, it was found that Table 3 ], statistically these results were significant (P < 0.05), suggesting higher level of toluene exposure among workers.
DISCUSSION
Workers engaged in shoe making, printing/painting work, cosmetic shops/saloons, petrochemical work, etc., have exposure to toluene. [1, 2] Chronic exposure to this volatile solvent can cause various health issues such as impaired function of liver, kidney, and CNS. [4, 3] Air monitoring of toluene is very time consuming, costly, and laborious. Therefore, it becomes necessary to develop a simple, easy, and cost-effective method for biomonitoring of this solvent. Urinary HA is recommended as an exposure biomarker for toluene. [11] Estimation of urinary HA, with the present method, is simple. This method has multiple advantages, and one of them is that it has excellent linearity in the working range, precise LOD and LOQ , with adequate accuracy and precision. For spiked urine sample (5 µg HA/ml), recovery value was found higher, possibly because HA was already present in urine (16 µg/ml) in higher quantities. Ideally, the recovery study should be done with urine containing lower levels of analyte. In case of analytic methods involving complex matrix like urine, recovery values in the range 80%-120% are acceptable. [23, 26, 27] The second advantage of the method is that urine used for exposure monitoring can be easily obtained and is noninvasive, unlike blood samples. Sample preparation is easy and cost effective than other methods described in the literature. Although the present method is good enough to use, ethyl acetate is used as an extraction solvent, it may cause irritation to eye, skin, and respiratory tract if its vapors are inhaled by laboratory workers. To check the validity of method, urine samples of exposed and unexposed groups were analyzed, and it was found that exposed individuals had significantly more HA. These results were statistically significant (P < 0.05), suggesting higher level of toluene exposure among workers. Our findings were similar to as reported by Duydu et al. (1999) . [28] Therefore, this method can be used in any laboratory having HPLC and can be used for routine bio-monitoring of toluene-exposed workers.
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